Salipraneb, Arrow’s Ipratropium/Salbutamol Nebuliser Solution launched.
Posted on 09th Mar 2009
Arrow Generics announces the launch of its Ipratropium/Salbutamol Nebuliser Solution 0.5mg/2.5mg per 2.5ml. The product is available in ampoule packs of 60. The combination product is launched in Breath (an Arrow sister company) livery under the brand name Salipraneb and further adds to the range of respiratory products available from Arrow.
Other respiratory range products already available from Arrow in Breath livery are Budesonide Nebuliser Suspension 0.5mg/2ml and 1mg/2ml, Ipratropium Nebuliser Solution 250mcg/1ml, 500mcg/2ml, Salbutamol Nebuliser Solution 2.5mg/2.5ml, 5mg/2.5ml and Terbutaline Nebuliser Solution 2.5mg/2ml. All 4 products are available in ampoule packs of 20.
For further information please contact us via the web page.